Latest News

STAT Plus: Pharmalittle: Poison control sees more cases with malaria drug; India to double HCQ output

And so, another working week will soon come to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Under the circumstances, however, our agenda is indefinitely going to be exceedingly modest. We hope to observe a day of rest — and a break from the barrage of disturbing events — and catch up on our napping and reading. We may also play a John Prine song or two. And what about you? This may be a good time to figure out how to stock the pantry while avoiding other humans. You could binge watch on the telly or take a needed walk. Or reach out to someone isolated who might like to hear your voice. Well, whatever you do, find a way to cope. And be safe. See you soon.

Since President Trump touted the decades-old malaria drug hydroxycholoroquine as a possible treatment for Covid-19, the number of exposure cases has more than doubled, Forbes writes, citing the American Association of Poison Control Centers. From March 18 through April, poison control centers managed 76 cases, up from 35 cases during the same period a year earlier. An exposure case refers to someone who may have been exposed to a toxic substances. Most of the cases were not toxic.

Continue to STAT Plus to read the full story…

Source link

Related posts

Molecular Studies of Neural Tube Defect Development in the Mouse Embryo


STAT Plus: Pharmalittle: Novo Nordisk plans still more layoffs; will pharma gain allies in the Senate?


Medical News Today: Invasive lobular breast cancer: Prognosis and statistics


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World